Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

Eli Lilly CEO David Ricks stated that 700,000 seniors newly enrolled in Medicare coverage have started GLP-1 medications, with 70 percent using Eli Lilly drugs, according to remarks made by the company. The Medicare coverage for GLP-1 drugs for weight loss began in July. The figures represent adoption rates since the coverage expansion launched.

Next story